HPBCD in vaccine development
Pharmaceutical Technology has published an evaluation from experts on vaccine development. According to recent market research, the vaccines market is
Tag: Covid-19
Cyclodextrins in the antiviral therapy
This review discusses the basic properties of the different cyclodextrin derivatives, their potential in antiviral formulations, and the prevention and
Nitric oxide and COVID-19
A clinical trial in United Kingdom confirms SaNOtize’s breakthrough treatment for COVID-19 SaNOtize R. & D. Corp, a Canadian Biotech
Combinatory treatment of Covid-19 with remdesivir and the repurposed drugs fluoxetine and itraconazole
The antiviral potential of the antifungal itraconazole and the antidepressant fluoxetine was tested on the production of infectious SARS-CoV-2 particles
A combinatory treatment of Hepatitis C drugs with Remdesivir show strong effectiveness against COVID-19
Science News reported that a combination of remdesivir, a drug formulated by SBECD and currently approved in the United States
Peripheral infiltration of remdesivir in 3 patients with COVID-19: Case series and discussion
The scientists from Netherland reported 3 cases on remdesivir infiltration in patients with Covid-19. In the first case, a 91-year-old
The talks of webinar “Meet the Experts: Applications of Cyclodextrins in the Pharma Industries” on youtube
The webinar held on Apr. 15-16, 2021 and organized by Cyclolab received wide attantion. It was in the afternoon Central
Inhaled budesonide in the treatment of early COVID-19
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Targeting Lipid Rafts as a Strategy Against Coronavirus
Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: characterization of electrospun- and lyophilized formulations
Veklury™ by Gilead Sciences, Inc., containing antiviral drug, remdesivir (REM) has received emergency authorization in the USA and in Europe